These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32486489)

  • 21. Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug.
    Dong Y; Furuta T; Sabit H; Kitabayashi T; Jiapaer S; Kobayashi M; Ino Y; Todo T; Teng L; Hirao A; Zhao SG; Nakada M
    Oncotarget; 2017 Dec; 8(67):111728-111741. PubMed ID: 29340087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM.
    Wightman SM; Alban TJ; Chen X; Lathia JD; Wang Y; Stark GR
    Transl Oncol; 2021 Nov; 14(11):101192. PubMed ID: 34365219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PNIPAAm-co-Jeffamine
    Heffernan JM; McNamara JB; Borwege S; Vernon BL; Sanai N; Mehta S; Sirianni RW
    Biomaterials; 2017 Oct; 143():149-158. PubMed ID: 28802102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.
    Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y
    BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribosomal protein S6 promotes stem-like characters in glioma cells.
    Shirakawa Y; Hide T; Yamaoka M; Ito Y; Ito N; Ohta K; Shinojima N; Mukasa A; Saito H; Jono H
    Cancer Sci; 2020 Jun; 111(6):2041-2051. PubMed ID: 32246865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.
    Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH
    Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Giordano C; Nuzzo S; Ricci-Vitiani L; Scognamiglio I; Minic Z; Pallini R; Berezovski MV; de Francisis V; Condorelli G
    Mol Ther Nucleic Acids; 2020 Jun; 20():176-185. PubMed ID: 32169805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
    Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
    Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
    BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome.
    Masliantsev K; Pinel B; Balbous A; Guichet PO; Tachon G; Milin S; Godet J; Duchesne M; Berger A; Petropoulos C; Wager M; Karayan-Tapon L
    Oncotarget; 2018 Jan; 9(3):3968-3979. PubMed ID: 29423098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived glioblastoma stem cells respond differentially to targeted therapies.
    Kanabur P; Guo S; Simonds GR; Kelly DF; Gourdie RG; Verbridge SS; Sheng Z
    Oncotarget; 2016 Dec; 7(52):86406-86419. PubMed ID: 27863440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.
    Singer E; Judkins J; Salomonis N; Matlaf L; Soteropoulos P; McAllister S; Soroceanu L
    Cell Death Dis; 2015 Jan; 6(1):e1601. PubMed ID: 25590811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance.
    Eom H; Kaushik N; Yoo KC; Shim JK; Kwon M; Choi MY; Yoon T; Kang SG; Lee SJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):87-95. PubMed ID: 29553850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
    Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
    J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.